HIV Populations Shift After Tuberculosis Associated Immune Reconstitution Inflammatory Syndrome: Implications For HIV Remission
Camille Lange, Maura Manion, Natalie Lindo, Robert J. Gorelick, Ana M. Ortega‐Villa, Kristi Huik, Christian Gonsalves, Gregg Roby, et al. (20 authors)
Research Square · 2020-11
Abstract
Abstract Tuberculosis associated immune reconstitution inflammatory syndrome (TB-IRIS) is a serious complication of starting combination antiretroviral therapy (cART). TB-IRIS emerges early after cART initiation and is characterized by rapid expansions of TB-specific CD4+ T cells and high levels of inflammatory mediators driven by CD4+ T cells. The effects of TB-IRIS on HIV populations are unknown, but could result in profound expansion and elimination of HIV infected cells via cellular activation and acute inflammation. We investigated immediate and long-term effects of TB-IRIS on HIV infected cells with and without TB-IRIS. We measured plasma HIV RNA, cell-associated HIV RNA and HIV DNA levels and compared genetic characteristics of HIV populations after prolonged cART. We found that TB-IRIS was associated with more diverse HIV DNA populations and HIV reservoirs after IRIS were distinct from pre-therapy populations, suggesting that TB-IRIS can shape the HIV reservoir with detrimental implications for HIV remission strategies.
MeSH terms
- Immune reconstitution inflammatory syndrome
- Cart
- Tuberculosis
- IRIS (biosensor)
- Immunology
- Immune system
- Human immunodeficiency virus (HIV)
- Antiretroviral therapy
- Medicine
- Inflammation
- Virology
- Biology
- Viral load